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ABSTRACT 
Intraoperative neurosurgical histopathologic diagnoses rely on evaluation of rapid tissue 
preparations such as frozen sections and smears with conventional light microscopy. Though 
useful, these techniques are time consuming and therefore unable to provide real-time 
intraoperative feedback. In vivo molecular imaging techniques are emerging as novel methods 
for generating real-time diagnostic histopathologic images of tumors and their surrounding 
tissues. These imaging techniques rely on contrast generated by exogenous fluorescent dyes, 
autofluorescence of endogenous molecules, fluorescence decay of excited molecules, or light 
scattering. Large molecular imaging instruments are being miniaturized for clinical in vivo use. 
This review discusses pertinent imaging systems that have been developed for neurosurgical use 
and imaging techniques currently under NADPH development for neurosurgical molecular 
imaging. 
 
INTRODUCTION 
Enhancing the gross extent of resection for gliomas improves patient survival.1,2 Extensive gross 
resection of low-grade and high-grade lesions not only significantly improves survival, but also 
increases time to recurrence. 3 The addition of gross fluorescent contrast agents, such as 5-ALA 
for the identification and resection of gliomas, provides further improvement in progression-free 
survival for glioma patients.4 This improvement is attributed to the increased rate of gross total 
resection, approximately double, with the addition of intraoperative tumor fluorescence contrast.4   
Increasing extent of resection must also aim to preserve eloquent brain as new postoperative 
neurological deficits are correlated with increased patient morbidity and decreased survival 
rates.5-7 With detailed preoperative planning, postoperative neurological morbidity may be 
insignificant with respect to the extent of surgery. 4,7,8  The general consensus leads us to believe 
that better techniques are required for improved surgical localization and removal of neoplastic 
tissue, and avoidance of healthy tissue to maximize the benefit of cytoreduction and risk 
reduction. 9  
Intraoperative microscopic evaluation of tissues is currently possible via frozen sections and 
tissue smears. Though useful, these techniques require anywhere from several minutes to 
occasionally an hour or more for feedback and can damage tissue, creating imaging artifacts, 10-13  
Also, given the nature of neurological tissue and neurosurgery, it is challenging to view three-
dimensionally orient tissue biopsies in a practical manner for localization and complete removal 
of tumor-positive areas. For this purpose, frozen sections and smears are typically used for their 
diagnostic confirmatory purpose rather than guidance for extent of resection. 
This article reviews pertinent current peer-reviewed manuscripts assessing in vivo and molecular 
imaging techniques with potential neurosurgical applications. We expand on the hypotheses, 
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benefits, and limitations of the current technologies for their application in neurosurgery. This 
review does not address functional brain imaging studies or studies examining basic tumor 
microenvironment and focuses on surgical oncology applications. The studies examining 
application of imaging technology by studying applicability in freshly resected and ex-vivo 
specimens from brain tissues were also included.  
 
Laser Scanning Confocal Endomicroscopy  
Laser scanning confocal endomicroscopy (LSCE) is a noninvasive imaging technique 
permitting in vivo histologic imaging with miniaturized endoscopic probes at cellular resolution. 
Cellular detail may be visualized by application of exogenous fluorescent contrast agents or by 
label-free imaging approaches that generate contrast based on endogenous fluorophores or tissue 
photon-scattering properties. 14-16 Currently, most diagnostic LSCE is conducted with use of 
exogenous contrast agents. Emerging label-free approaches include tissue visualization via auto-
fluorescence, in which endogenous fluorophores are excited to generate fluorescence contrast 
and reflectance mode confocal microscopy which visualizes tissues based on the variable 
refractory differences of microscopic structures. 17   
One advantage confocal microscopy provides over conventional microscopy is its ability 
to optically section through thick tissues. To allow for optimum tissue contact, the microscope 
can be introduced to the tissues endoscopically or topically via a miniaturized optical apparatus. 
Alternatively, excitation light and images can be transmitted to and from the tissues to the 
microscope via a flexible imaging fiber-optic conduit. The clinical utility of confocal 
endomicroscopy for histologic evaluation is well established for evaluation of the gastrointestinal 
tract18,19 and is being extensively investigated for utility in multiple other organ systems, 
including the brain.  
Differences in morphologic appearance of tissue in ex-vivo specimens with topically 
applied fluorescent agents and in vivo specimens with injected agents must be noted. Injected 
sodium fluorescein highlights a fluorescent extracellular background with nuclear cellularity 
representing dark shadows. Strong fluorescence signal is usually demonstrated in tumor tissue 
due to increased extravasation of the agent and small hemorrhages.20  Also, fluorescent vessels 
appear bright and are simple to identify.20 Another issue with in vivo images obtained with 
confocal systems is the motion artifact that complicates image interpretation. Motion artifacts 
during acquisition of images result from movements of the portable probe or of the tissue 
because of pulsation and other movement. This increases the number of images needed to be 
captured in vivo compared with ex vivo imaging before diagnosis. 21 Development of imaging 
systems with higher frame rates will minimize motion artifacts in future devices.    
Although cellular and architectural detail is often sufficient, diagnostic challenges may 
result from the unconventional plane of sectioning.  In most areas of the body, interpretation of 
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the images is dependent to some extent on the plane of tissue at imaging. LSCE provides en-face 
sectioning of the tissue and can be contrary to the conventional plane of sectioning for histology 
and may make interpretation of small foci of invasion more challenging. 22 
Current FDA-approved diagnostic fluorescence contrast agents for neurosurgery include 
fluorescein sodium (FNa), indocyanine green (ICG), 5-aminolevulinic acid (5ALA), and tumor 
paint (BLZ-100). These agents are in various levels of clinical testing and approval and have 
been thoroughly reviewed in the literature. 23 Fluorescein sodium and ICG are nonspecific agents 
that provide cellular contrast between all structures within the field of view. Fluorescein sodium 
has the advantage of excitation and emission within the visible wavelength, allowing real-time 
macrofluorescent imaging when viewed through the optics of a surgical microscope. Indocyanine 
green is an infrared fluorophore that allows imaging of deeper cellular structures; however, ICG 
requires digital processing for viewing due to emission wavelength beyond what is detected by 
the human eye. Five-aminolevulinic acid and BLZ-100 are specific fluorophores and selectively 
label tumor cells within the brain. Their ability to exploit the selective labeling to safely enhance 
extent of resection is currently in various phases of clinical review.24    
Outside of neurosurgery, the most common fluorescent contrast agents for clinical 
applications are acriflavine hydrochloride 0.05%, fluorescein, and indocyanine green (ICG).25-29 
When fluorescein and topical acriflavine are combined, it is possible to calculate nuclear 
cytoplasmic ratios, which are useful indicators for cellular differentiation. Simultaneous imaging 
of multiple fluorophores is now possible with several clinical LSCE systems with multichannel 
imaging capabilities.30 
Flexible Probe Confocal Endomicroscopy: Images obtained utilizing a flexible probe 
attached to a LSCE have an overall good quality and are comparable to conventional histologic 
images. 31 The flexible imaging fiber optic extends the imaging field by transmitting the image 
through a bundle of optical fibers (Fig. 1a). Each fiber acts to transmit light corresponding to the 
light intensity of the area imaged. When multiple fibers are bundled together, each fiber acts as a 
pixel; therefore the resolution of the imaging system depends on the number and size of fibers 
within a bundle.32 The space between the individual optical fibers superimposes a honeycomb 
pattern over the image. Although the resolution and quality of images is reduced because of the 
honeycomb artifact, the fiber optic is very small and flexible compared with miniaturized or rigid 
microscopes. This allows for intraoperative freedom when imaging.32  
Charalampaki et al. studied the neurosurgical utility of confocal laser endomicroscopy in 
150 patients and ex vivo specimens. Tumors examined using the microscope ranged from benign 
and malignant primary brain tumors, to metastases. In general, both benign and malignant tumors 
in the brain exhibited increased cellularity and vascularity. Vascular proliferation appears as dark 
spots with topical application of most fluorescent agents and appears bright with intravascular 
injection of fluorescent agents in vivo. 31,33 The use of fluorescein as an injectable agent for in 
vivo diagnoses demonstrated the ability to differentiate normal from abnormal tissue. 33 Five-
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aminolevulinic acid injection resulted in images that were harder to interpret. 33 Large structural 
formations were generally easy to identify in the tissues. Examples include psammoma bodies, 
calcifications, Rosenthal fibers, palisading, and pseudorosettes (Fig. 1b).  
For the same reason, other studies found that the sensitivity of endomicroscopy in 
diagnosing meningiomas with identifiable structures such as psammoma bodies to be 
significantly higher. 21 However, confocal endomicroscopy was unable to differentiate high-
grade from low-grade meningiomas with a satisfactory degree of reproducibility and confidence. 
31
 This demonstrates one of the main limitations of in vivo microscopy. It is apparent that it is 
difficult to interpret cytologic features of pleomorphism, nuclear cytoplasmic ratios, and general 
atypia.31  Also critical histologic features of mitosis, endothelial proliferation, and necrosis are 
not readily identifiable. 33 Detection of some of these features is possible using miniaturized 
confocal endomicroscopy, as discussed later, and this demonstrates the limitation of a fiber optic 
in producing high-quality images.   
Rigid Probe Confocal Endomicroscopy: Imaging devices composed of a confocal 
microscope with an attached rod lens are available34. The rod lens acts as a conduit for the 
transfer of images from the tissue surface to the microscope objective. Although the glass lens is 
not flexible, images produced using this method tend to have a better quality and are less 
pixelated when compared with those of flexible fiber optics.35   
The EndoMAG1 is a confocal endomicroscope with a rigid probe that was investigated 
for neuro-oncological applications. This microscopy technique achieves a resolution of 2µm and 
has a field of view with a diameter of 300µm.34 Examination of the specimens using the rigid 
probe confocal system generated images comparable to other confocal systems34 and allowed 
differentiation between grey and white matter, membranes, and diagnosis of different tumor 
types.  
In certain tumors, the diagnostic information achieved with the microscope were 
sufficient; for example, meningiomas with prominent psammoma bodies were readily visualized, 
however, as with other confocal systems, interpretation of other common histologic diagnostic 
criteria was challenging34 (Fig. 2). An interesting advantage of the EndoMAG1 confocal system 
imaging is that images produced after the addition of a contrast agent (methylene blue) were 
similar to the results produced by imaging of native brain without the addition of a contrast 
agent; this finding suggests the ability of this microscope in detecting autofluorescence.  
Miniaturized Confocal Microscopy: Miniaturization of the optical components of a 
confocal microscope converts it into a hand-held rigid probe with a diameter less than 10mm. 
This tool provides portability and direct microscopic imaging of tissues when integrated into 
endoscopic and surgical procedures.31 Commercially available miniaturized confocal 
microscopes such as the Optiscan are currently available for clinical and research utility (Fig 3a). 
The addition of fluorescent contrast agents such as fluorescein or acriflavine are usually required 
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for the production of interpretable images. The images produced using the system are 
theoretically superior to those obtained using a fiberoptic or rigid rod lens conduit as there is no 
deterioration in the image quality by the conduit.  
In fact, one study demonstrated the ability of this microscopy technique in detecting 
subnuclear structures such as nucleoli with acriflavine as a contrast agent.20  Detection of mitoses 
in vivo was also possible and was demonstrated within high grade gliomas.20 In studies 
examining the accuracy of the confocal system imaging of ex vivo biopsies obtained from the 
brain, or animals, strong discerning ability of the microscope was demonstrated with cytological 
and architectural detail comparable to histology. Detection of the transition zone between 
neoplastic and healthy tissue was considered easy in grafted gliomas20 (Fig. 3b). Additionally, 
detection of single malignant cells distant from the main tumor was possible.20  
Meningiomas are generally among the tumors readily identifiable using in vivo 
microscopy given their architectural cytostructure. In a study examining grafted meningiomas in 
mice using the miniaturized handheld confocal system, variable histologic variants were 
demonstrable in vivo, including the ability of this microscope to demonstrate small foci of 
invasion among aggressive meningiomas.21,22 Although this imaging modality is able to identify 
most other tumors studied, such as meningiomas, schwannomas, epidermoid cysts and 
craniopharyngiomas, 20,31 it may require that multiple images be acquired before an image with 
enough data to make a diagnosis is captured.  
The number of in-vivo images captured on average before a diagnostic image is produced 
is approximately 14.21 This requires a mean imaging time of a single field of approximately 5.8 
minutes, which is significantly shorter than the time required for frozen section interpretation.36 
However, large area scanning of the tumor bed may be too time consuming and not practical, and 
confocal imaging in general may be more useful in imaging suspicious foci within the tumor 
bed.22   In the study by Martirosyan et al., 21 the sensitivity (91% for gliomas and 97% 
meningiomas) and specificity (91% for gliomas and 97% of meningiomas) of in -vivo acquisition 
were comparable to those of frozen sections.21 
Advantages of LSCE 
• Generates high quality of images with good nuclear and subnuclear detail, 
allowing for accurate diagnoses 
• High accuracy for identifying various types of tumors 
• Can be integrated into hand-held probes or flexible fiber optics for practical 
application during surgery 
• Shows good visibility of vascularity and vascular structures with injected 
fluorescent agents 
• Can be combined with confocal reflectance microscopy for multimodal 
microscopy 
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Disadvantages of LSCE 
 
• Usually requires the addition of contrast agents 
• Difficulty in identifying some histologic features such as mitoses and nuclear 
pleomorphism 
• Associated with significant motion artifact in vivo 
Confocal Reflectance Microscopy  
 Confocal reflectance microscopy (CRM) is a low-energy optical imaging modality that 
can rapidly assess tissue samples without physical manipulation or application of exogenous 
contrast agents.37 CRM generates contrast based on tissue specific backscatter and reflection of 
photons.. CRM introduces a small fraction of energy into tissue compared with fluorescent 
imaging techniques since it does not rely on fluorophore excitation.  
 One of the main advantages of confocal reflectance microscopy is that it generally does 
not require preparation or staining of the tissues for imaging, although acetic acid has been 
shown to enhance nuclear contrast.38-42 Acetic acid causes compaction of nuclear chromatin 
making them appear brighter.38  In xenograft and clinical biopsies, CRM have shown utility for 
providing detailed histopathologic images of normal brain and neoplastic brain (Fig. 7a(b)), (Fig. 
7b(b)). Like confocal fluorescence microscopy, confocal reflectance microscopy possesses the 
ability to change the depth of imaging, creating optical sections within the tissue. However, since 
the detected signal is a scattered signal, the depth of imaging is limited to tissues with high 
scattering.  
 Furthermore, work in ex-vivo and animal models suggests CRM can provide detailed 
microscopic interrogation without alterations to the molecular integrity of the tissues.43,44 Since 
CRM is a nondestructive technique, It may be useful in determining cellular and viable tissues 
prior to biobanking.31 Further work is required to determine if the ex vivo imaging utility of 
CRM can be translated for in vivo applications.  Fiber optic probe integration with confocal 
reflectance microscopes allowing for flexible endoscopic imaging has been demonstrated, but 
not yet customized for neurosurgical applications.45,46 
Advantages of CRM 
• Generates high-resolution images 
• Delivers low energy to tissue 
• Can optically section thick tissue 
• No exogenous contrast agents required 
• Does not disrupt tissue molecular integrity 
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Disadvantages of CRM 
• Limited to imaging depth of 150 microns, dependent on tissue-scattering 
properties 
• Requires learning curve for image interpretation 
• Technology has not been miniaturized for clinical neurosurgical use 
Raman Spectroscopy 
 Raman spectroscopy is an analytical method that relies on scattering of light by vibration 
of molecules within a given specimen.47 The vibrating molecules and bonds shift a small fraction 
of the scattered photons into a new frequency. These shifts correspond to the chemical 
composition of the molecule. Fatty acids, for example, produce signature spectral shifts, allowing 
their identification.  
 Microscopy techniques that rely on Raman scattering may be direct, in which a shift 
characteristic for a molecule could be used to map its distribution within an area of tissue. 
Alternatively, thousands of Raman spectra can be recorded from different spots within a 
microscopic field and an image is generated based on the aggregate compositions within the 
area. Several imaging techniques based on the Raman concept have evolved and have been 
studied in several areas of the body, including the brain.  
 Earlier spectroscopic studies of excised human gliomas and other brain tumors showed 
that spectroscopy can differentiate grey from white matter48 and necrotic (cholesterol rich) from 
viable tissues. 49 These distinctions are possible because of significant differences in lipid 
compositions of these compartments.  Unfortunately, the method lacks sufficient sensitivity to 
differentiate tumor from normal brain tissue.50 Gliomas (grades II – IV), studied in early 
spectroscopy studies, showed spectra identical to gray matter.50 Further developments using near 
infra-red spectroscopy allow discrimination between tumor and normal brain. 51,52 In addition to 
its discriminatory advantage, the use of near infra-red Raman spectroscopy of the brain reduces 
the risk of tissue damage.  
 Unlike fluorescence microscopy, Raman spectroscopy and microscopy do not require the 
addition of exogenous contrast agents. Other advantages include the ability to transmit the 
measurements through a fiber optic hand held probe allowing for intraoperative use. 53-56 (Fig. 
4a). Perhaps the main drawback of the conventional spontaneous Raman scattering in the brain is 
lack of satisfactory sensitivity to detect minute Raman shifts necessary for tumor diagnosis. This 
results in decreased discriminatory ability and long acquisition time which may result in tissue 
damage.  
 Coherent Raman spectroscopy (CRS) has significantly improved Raman spectroscopy 
sensitivity. CRS typically uses two pulsed laser sources and drives the Raman signal collected 
toward an easier-to-detect spectrum (away from interference with emitted fluorescence noise). 
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This allows considerable isolation and magnification of the signal, thus increasing sensitivity. 
The two major methodologies of CRS studied in the brain are coherent anti-stokes Raman 
scattering (CARS) and stimulated Raman scattering (SRS). Stimulated Raman spectroscopy 
mapped to graphical representation demonstrated mitotic figures along with detailed cytological 
and architectural features (Fig. 4b). CRS techniques also improve the quality of the signals 
collected by measuring the spectra within a thin slice of tissue, as opposed to collecting 
aggregated spectra from depths of up to 1mm.57 
With a high specificity (91%) and sensitivity (93%), Jermyn et al. demonstrated the powerful 
ability and accuracy of SRS in identifying malignant tissues intraoperatively in human brain.55  
In addition to the ability of identifying densely malignant and normal tissues, the SRS probe has 
the ability of detecting normal brain infiltrated with as few as 17 cancer cells per 0.0625mm.255  
Advantages of Raman Spectroscopy 
• Can accurately detect brain tumors, including gliomas (grades 2-4) 
• Coherent Raman methods provide high sensitivity and resolution for detecting 
single malignant cells 
• No contrast agent is required for brain imaging 
• Can be integrated in endoscopic or hand-held probes 
 
Disadvantages of Raman Spectroscopy 
• Limited to imaging depth of 150 microns 
• Interference from extraneous operative light may require that operative room 
lights be turned off during analysis 
• Blood in the operating field and debris may interfere with spectroscopy 
 
Optical Coherence Tomography 
 Optical coherence tomography (OCT) is a well-established medical imaging technique 
for obtaining cross-sectional microscopic images of biological tissues such as the retina. Its use 
has been rigorously investigated in several medical disciplines, including ophthalmology, 
dermatology, gastroenterology, and others. The practicality of obtaining high-resolution cross 
sectional images with no risk of tissue damage has made its use in ophthalmology routine for 
evaluation of the retina at a microscopic scale.58-60 Its functional and imaging concepts are 
similar to an ultrasound, with the difference being that it uses light instead of sound reflection to 
visualize structures at varying depths in the tissue.  
 Unlike other methods that offer optical slices in a plane parallel to the tissue (en-face), 
the attractiveness of this method lies in its inherent ability to provide deep cross-sections of the 
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tissue (1-2mm).61 This is achieved by using long wavelength light, such as infrared light for 
imaging.  OCT also does not require the addition of contrast material or preparation of the tissues 
because it uses the native refractive properties of the tissue. Unfortunately, standard OCT 
produces images at a resolution of roughly 10 microns, which is not sufficient for adequate 
cellular detail, but can offer information such as disruption of myelinated axons at areas of 
malignant invasion, or identification of sheets of tumor cells versus normal brain.62  
 Studies investigating the utility of OCT in the brain showed the ability of spectral-domain 
OCT imaging to delineate gliomas (low and high grade) from normal brain.62 Multiple studies 
have also demonstrated the ability of OCT equipment to image tissue at a far working distance, 
allowing their integration into the optical path of surgical microscopes.62,63 OCT may also be 
integrated in neuroendoscopic probes for microscopic imaging during neuroendoscopy. 64 
Although most OCT methods demonstrated their ability to identify tumors (including low-grade 
and high-grade gliomas), they lacked sufficient resolution for identification of the normal brain 
infiltrated by individual malignant cells at the edges of the tumor cavity. 62,63 However, detection 
of small areas of residual tumor at the edges of tumor cavity is possible using continuous 
imaging by integrating the OCT in the optical path of the surgical microscope for non-contact 
imaging.63  
 Nonetheless, tumoral hemorrhage can compromise the interpretability of this modality.63 
Further studies are required to study the effectiveness of this method.  The advantage of OCT 
over other methodologies is its ability to image at depths greater than 1mm. It has been shown 
that OCT may be used to identify subsurface foci of metastatic tumor (such as melanoma)65 (Fig. 
5). Current developments in optical coherence tomography have allowed for improved imaging 
resolution 66 and expanded the area of imaged surfaces. 67,68 Further OCT advances include the 
refinement of micro OCT technologies that allow the imaging of subcellular structures.69 
Advantages of OCT: 
• Provides cross-sectional morphologic assessment at a resolution of 10microns 
• Does not require addition of contrast materials 
• Utilizes near infrared or infrared light source with no risk of tissue damage 
• Performs images at a distance and can therefore be integrated into surgical 
microscopes 
• Similarly, may also be integrated into rigid endoscopic probes  
• Imaging depths of more that 1mm exceed those of fluorescent methods 
• Automated OCT and full-field OCT allow for scanning of large fields of view at a 
microscopic level 
Disadvantages of OCT 
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• Lacks sufficient cellular detail for detection of infiltrating malignant tumor cells 
at tumor margins 
• Interference from extraneous operative light can be problematic 
• Cannot visualize optically opaque tissues or tissues beyond an opaque barrier 
Multiphoton Microscopy 
 Multiphoton imaging, including two photon imaging,  has the advantages of imaging 
tissue at greater depths than traditional confocal (linear) microscopy and the ability to excite 
endogenous fluorophores with a fraction of the energy compared with standard fluorescence 
imaging modalities.70 Fluorescence imaging of brain tissue without the addition of contrast 
agents is possible with the aid of endogenous fluorophores such as NADPH, porphyrins, flavins, 
collagen, elastin, and lipofuscin.  The inherent limitation of using endogenous autofluorescence 
is that the endogenous fluorophores are present at relatively low concentrations and require high-
intensity fluorescence excitation for imaging. At such high-intensity requirement, traditional 
fluorescence microscopy using a continuous light beam may result in tissue damage.  
 .  
 Multiphoton imaging utilizes femtosecond-pulsed lasers. Using short pulses of lasers 
maximizes the intensity of light used without impacting cell viability. These devices have 
excellent resolving power in normal and abnormal brain tissue  without the addition of 
exogenous contrast materials71,72 (Fig 6b). In a study by Leppert et al., ex vivo multiphoton 
imaging provided identification of single malignant cells permeating normal brain at the tumor 
margins (Fig 6a).  This imaging modality has been miniaturized and incorporated into prototype 
endoscopes currently being evaluated in the basic sciences.  Though not yet studied in brain in 
vivo, these endoscopes have potential for neurosurgical utility. 73,74   
Advantages of multiphoton microscopy: 
• High sensitivity and specificity with good discriminatory ability in the brain and 
high cellular resolution 
• Allows delivery of high-intensity excitation pulses without photodamage 
• Allows fluorescent imaging of endogenous fluorophores (autofluorescence), 
therefore no exogenous contrast material needed 
• Can be integrated with other imaging modalities, such as fluorescent lifetime 
microscopy to increase imaging specificity and sensitivity 
• Can be integrated in endoscopic and hand-held probes 
Limitations of multiphoton microscopy: 
• Technically demanding microscopy method that may not be easily integrated in 
neurosurgical equipment 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 12 
• Slower imaging acquisition rate 
•  limited by movements such as pulsation that introduce motion artifacts  
Fluorescence lifetime microscopy (FLIM) 
 Traditional fluorescence imaging observations measure properties such as fluorescent 
intensity and frequency. An additional observable dimension is fluorescence lifetime and may 
add valuable information about molecular composition.  Fluorescence lifetime is the average 
amount of fluorescence decay once a fluorophore is excited, and typically occurs within 100 
nanoseconds. This lifetime is proportional to the quantity of excited fluorophores. The advantage 
of measuring fluorescence lifetime instead of fluorescence intensity is that two different 
molecules at different concentrations may emit the same fluorescence intensity; however, one 
may have a longer lifetime and can therefore be identified.  
 In order to measure the fluorescence lifetime; a laser pulse excites the specimen and starts 
a “stopwatch”. Contrast is generated by analysis of decay times within sampled areas, allowing 
for spatial mapping and image construction. FLIM offers high sensitivity with only a few 
fluorophore molecules required for detection. This allows for low excitation intensity, preserving 
viability of specimens under lengthy observations. FLIM may therefore be added to complement 
most fluorescence modalities, including confocal and multiphoton microscopy and macroscopic 
fluorescent imaging.  FLIM has been miniaturized for endoscopic large area imaging with 
development of a clinical instrument on the horizon.75  
 FLIM has been utilized reliably to differentiate glioma cell lines based on distinct 
endogenous fluorophore lifetime profiles compared with other tumor cell lines.71 Importantly, 
FLIM offers good delineation between gliomas and normal brain with the ability to resolve 
single malignant cells in the background of normal brain at the diffuse edges of glioma without 
the addition of any exogenous contrast material. 71  
FLIM combined with multiphoton imaging generates additional contrast between normal and 
neoplastic brain. The pulsed light sources utilized for multiphoton imaging allow integration of 
fluorescent lifetime measurement as a fourth and additional dimension.71,72,76 This provides 
additional contrast between tumor and normal brain,76 and may be utilized to improve the 
contrast of exogenous fluorophores such as protoporphyrin IX. 76  
Advantages of FLIM: 
• High-resolution imaging in combination with multiphoton and confocal imaging 
• Does not require the addition of contrast materials 
• Low energy delivered to tissue 
• May generate contrast between cancer-specific molecules that may be overlooked 
via standard fluorescence 
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• Combination with conventional macroscopic fluorescence imaging and 
endoscopy allows for FLIM imaging of large areas of tissues. 
Disadvantages of FLIM 
• High cost of instrumentation 
• Slow image-acquisition rate 
• Commercial device not currently available 
 
 
Mass Spectrometry 
 Mass spectrometry is an analytical technique that sorts ions and small molecules based on 
their charge and mass.77 Different mass spectrometry techniques have been applied 
intraoperatively to guide surgical resection of tumors. These methods rely on the analysis of 
ionized gas produced from the electro-dissection or laser ablation; different signature patterns of 
molecular composition between normal and abnormal tissues are then determined.   
 The utility of mass spectrometry in tumor resection has been demonstrated in oncologic 
surgery. 78,79  In one study, a vacuum is integrated with the electro-dissection instrument to allow 
a constant stream of vaporized gas to be analyzed in real-time. The premise of its use in the brain 
is based on the fact that certain onco-metabolites such as 2-hydroxyglutarate (2-HG) are 
produced by the tumor cells and are otherwise at extremely low concentrations within normal 
tissues. 80 Of note, 2-HG is also a surrogate for IDH mutations, adding to the value of this 
method in determining the presence of this mutation. 81,82 In addition to analysis of a single or 
multiple metabolites, complex protein and molecule patterns produced from analysis of different 
tissues differentiate normal and diseased tissues. 83,84  
 Interestingly, metabolite profiles are able to distinguish between primary glioma 
subtypes, predict transformation and trajectories of low-grade and high-grade gliomas.85 In one 
study examining the intraoperative use of mass spectrometry, 84 samples from biopsied sites were 
placed on a slide and then analyzed using mass spectrometry. No prior preparation of tissue was 
required otherwise. The results were then mapped stereotactically based on their biopsy site, 
allowing for surgical guidance. Another method has the ability to directly analyze ultrasonically 
liquefied brain tissue for real-time analysis at their primary site.86 These methods have been 
tested in ex vivo specimens, further studies are required to test their feasibility for direct in-vivo 
intraoperative use and accuracy. 
 
Advantages: 
• Fast analysis of tissues allowing accurate identification of diagnostic molecular 
profiles 
• Allows detection of molecular changes within tumors such as IDH-1 mutations 
• Does not require staining or preparation of tissues 
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Disadvantages: 
• Analysis requires vaporization or liquefaction of tissue 
• Metabolite profiles for different tumors need to be established as a reference  
• Method is not practical for examination of large areas of tissue 
 
Multimodal Microscopy 
Multimodal confocal reflectance and fluorescence microscopy: Confocal microscopy 
that simultaneously combines both reflectance and fluorescence modes provides complimentary 
information and enhances the diagnostic ability of both imaging techniques. Current benchtop 
confocal microscopes offer imaging in both reflectance and fluorescence modes. As described 
previously, each mode offers advantages and when combined together, the diagnostic ability of 
this form of microscopy is brought one step closer to resembling standard histology.  
In general, reflectance mode is useful for assessing tumor architecture87,88 while 
fluorescence mode provides better cytological detail.87,88 Two separate studies examined ex vivo 
brain tumor samples in both reflectance and fluorescence modes using different microscopes. 
Combination of the confocal modes still required the addition of a fluorescent contrast agent and 
allowed easy identification of meningiomas that demonstrate recognizable whorling patterns 
appreciated via reflectance and nuclear details such as pseudo-inclusions appreciated via 
fluorescence88 (Fig. 7). Combining confocal modes allowed identification of essential diagnostic 
criteria such as cellularity, vascularity, necrosis, and infiltration; however, mitoses were not 
identifiable.87   
Distinguishing white and gray matter is possible with a very high degree of certainty via  
combination of fluorescence and reflectance microscopy17. On reflectance mode, gray matter has 
a finely granular appearance while white matter shows thicker “cotton-like” appearance. The 
addition of fluorescence demonstrates lower cellularity in white matter.17  Low-grade gliomas 
that offer only subtle changes in cellularity and cytologic atypia are more challenging to 
diagnose using fluorescence alone. Interestingly, reflectance images show a different structural 
pattern in low grade gliomas that are distinguishable from normal brain. 17,88 This structural 
lattice formed by cellular processes, not visualized in standard hematoxylin and eosin stained 
tissues, complements the diagnostic utility of this method.88 This pattern is especially useful if 
the cellularity and other cytological features are not completely diagnostic of a low-grade 
glioma. 88  
Also, absence of the glial meshwork on reflectance mode may suggest a non-glial or 
metastatic tumor.17 Multimodal confocal microscopy therefore combines the advantages of both 
reflectance and fluorescent microscopy. It offers a high sensitivity and specificity for detecting 
normal versus abnormal brain tissue, 95% and 100%, respectively.17 An additional advantage of 
multimodal confocal reflectance and fluorescence microscopy is the ability of pseudocoloring to 
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produce images that resemble hematoxylin and eosin stains. Pseudocoloring fluorescence images 
in blue and reflectance in pink generate images that closely resemble hematoxylin and eosin 
stained histology.   Unfortunately, this modality is yet to be miniaturized for practical clinical 
use. 
Multimodal two-photon microscopy combined with coherent anti-stokes Raman 
spectroscopy (CARS): Combination of two-photon microscopy and Raman spectroscopy for 
potential intraoperative diagnosis of brain tumors has been studied. 89 This method most likely 
provides the best imaging quality in comparison with standard histology without the addition of 
contrast agents. The addition of Raman spectroscopy enhances the structural contrast. Structures 
rich in fatty acids provide strong intensity signals and allow good nuclear membrane and 
cytological delineation when mapped in correspondence to images produced using two photon 
microscopy (Fig. 8).  
Necrosis is especially easier to identify due to the sensitivity of Raman spectroscopy for 
detecting cholesterol rich necrotic zones. The two-photon microscopy component provides 
adequate cytological and nuclear detail without the aid of fluorescent agents (Fig. 8).  Further 
studies are required to determine the accuracy of this method and comparison with other 
methods. One significant limitation of this method is the time required for acquisition. A single 
image requires approximately 30 seconds, which results in imaging times of around 2 hours if an 
imaging mosaic of a large area is obtained. Miniaturization of this method is not currently 
available for practical integration in neurosurgery. 89  
Pertinent studies of in-vivo imaging in neurosurgical oncology are summarized in Table 1. 
Technical comparisons among different imaging modalities are reviewed in Table 2. 
 
CONCLUSIONS 
 The advent of clinical molecular imaging has provided a unique means to obtain real-
time histopathologic images of tumors and their microenvironments. Multiple technical 
advancements have allowed direct real-time molecular evaluation of brain tissue, providing a 
practical approach to enhancing the extent of tumor resection. Moreover, some of the more 
useful technologies have not been yet readily integrated into the operating instrumentation.  
 Currently, flexible and miniaturized confocal microscopy (LSCE) as well as Raman 
spectroscopy are among the most researched and utilized in neurosurgical oncology.  In our 
opinion, miniaturization and customization of multi-modal imaging technologies for 
neurosurgical application may have the greatest potential for practical clinical application. 
Additionally, the use of imaging modalities that do not require the addition of contrast agents 
may increase adoptability and research. However, further technical advances, are still required to 
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improve acquisition rates, cost, and the ability to integrate these methods into neurosurgical 
procedures.  
One of the basic limitations of most in vivo microscopic methods is their inability to practically 
and conveniently scan large areas of tissue at various magnifications. Development of larger area 
scanning methods for targeting areas of interest may further improve the practicality of in vivo 
microscopy. Unfortunately, most of the modalities discussed herein have been investigated 
only on ex vivo specimens. Imaging in vivo introduces challenges from motion artifact and 
bleeding interference that make interpretation of images more challenging. Additionally, in vivo 
and real-time mass spectrometry and Raman spectroscopy already have the potential to provide 
immediate molecular information intraoperatively. Arguably, accurate pathological diagnosis 
may not be the aim of in vivo microscopy and rather an accurate distinction between normal and 
abnormal tissues is sufficient. Large multi-center clinical trials involving neurosurgeons and 
neuropathologists are therefore needed to validate the currently well established in-vivo imaging 
technologies for identification of residual tumor within tumor beds.  
 
 In vivo microscopy is an emerging clinical tool which can provide neurosurgeons and 
neuropathologists real-time intraoperative histologic information. This technology is under 
development with the goal of providing clinicians with immediate information for differentiating 
tumors from normal brain, and possibly providing immediate histopathologic diagnoses. These 
techniques will continue to evolve and those with the greatest clinical utility will be elucidated. 
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Figure Legends 
Figure 1: a: fiberoptic probe with emitting blue light to be placed on tissue of interest for in-vivo 
imaging. b: Confocal image obtained through flexible fiber-optic probe demonstrating a 
Rosenthal fiber within a pilocytic astrocytoma. The pilocytic astrocytoma also displays the 
typical spider-web structure. Reproduced with permission:  Charalampaki P, Javed M, Daali S, 
Heiroth HJ, Igressa A, Weber F: Confocal laser endomicroscopy for real-time 
histomorphological diagnosis: our clinical experience with 150 brain and spinal tumor cases. 
Neurosurgery 62 Suppl 1:171-176, 201, by permission of, Congress of Neurological Surgeons, 
Oxford University Press, provided by Oxford University Press and Copyright Clearance Center. 
 
Figure 2: Images acquired using rigid probe confocal microscope. a: image of glioblastoma 
showing diffuse growth with indistinguishable cellular borders, high nuclear cellularity (white 
spots) and nuclear pleomorphism . b: image of a psammomatous meningioma with multiple, 
round, hypo-fluorescent psammoma bodies.34 Reproduced with permission from Breuskin D, 
Divincenzo J, Kim YJ, Urbschat S, Oertel J: Confocal laser endomicroscopy in neurosurgery: a 
new technique with much potential. Minim Invasive Surg 2013:851819, 2013 
Figure 3.Images and setup using miniaturized confocal laser endomicroscope. a: A miniaturized 
confocal laser endomicroscopy setup in anesthesized tumor-bearing rats b: A- Gross view of 
intracranial windows, transition zone between health brain and tumor seen in circle on the left 
side. B; appearance of vessels after intravenous injection of FITC-dextran showing massive 
extravasation, and ‘bleeding’ of fluorescence in interstitial zones. C,D; normal vessel 
morphology with no extravasation following injection of FITC-Dextran. E; Histologic 
appearance of transition zone with cellular tumor on the right. G; in-vivo appearance of 
transition zone with cellular tumor on the right.20 Reproduced with permission: Foersch S, 
Heimann A, Ayyad A, Spoden GA, Florin L, Mpoukouvalas K, et al: Confocal laser 
endomicroscopy for diagnosis and histomorphologic imaging of brain tumors in vivo. PLoS One 
7:e41760, 2012 
Figure 4: a: Images and setup of in-vivo Raman spectroscopy. (A) Raman spectroscopy setup 
with Raman probe and high-resolution CCD spectroscopic detector resulting in waveforms 
specific to different tissue types. (B)Raman spectroscopy probe used in-vivo, schematic 
diagrams illustrates excitation of molecules resulting in waveforms specific to different 
molecular species aiding diagnosis.55 From Jermyn M, Mok K, Mercier J, Desroches J, Pichette 
J, Saint-Arnaud K, et al: Intraoperative brain cancer detection with Raman spectroscopy in 
humans. Sci Transl Med 7:274ra219, 2015. Reprinted with permission from AAAS. b:  (A) MRI 
showing glioblastoma with ring enhancement (arrowhead) (B)Nuclear crowding and 
pleomorphism seen in both stimulated raman spectroscopy (SRS) (left) and hematoxylin & eosin 
(H&E) (right) microscopy. (C) vascular proliferation demonstrated as tortuous vassels on SRS 
microscopy (left, arrowheads) and with periodic acid Schiff staining (right, arrowhead). (D) 
Mitotic figures are visible (arrowheads) with SRS microscopy (left) and H&E staining (right). (E 
and F) Non-enhancing, low-grade oligodendroglioma (arrowhead, E) consists of nested cellular 
tissue with “fried-egg” nuclearmorphology (arrowheads, F) causing minimal axonal disruption 
on SRS imaging (left), correlates with neurofilament immunostaining (right). (G and H) 
“Chicken wire” blood vessels in oligodendroglioma (arrowheads, G) and perineuronal satellitosis 
is visible in both SRS and H&E. From [Ji M, Lewis S, Camelo-Piragua S, Ramkissoon SH, 
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Snuderl M, Venneti S, et al: Detection of human brain tumor infiltration with quantitative 
stimulated Raman scattering microscopy. Sci Transl Med 7:309ra163, 2015]. Reprinted with 
permission from AAAS 
Figure 5. Optical coherence tomography cross-sectional imaging C-D; showing subsurface 
metastatic intracortical melanoma (arrow head) . E-F; corresponding histologic sections 
demonstrating subcortical metastatic melanoma. G; digital en-face mosaicing produced by 
stitching multiple crossectional images (lines A and B) allowing a topologic localization of 
subcortical metastatic melanoma65. Reproduced with permission from Boppart SA, Brezinski 
ME, Pitris C, Fujimoto JG: Optical coherence tomography for neurosurgical imaging of human 
intracortical melanoma. Neurosurgery 43:834-841, 199. By permission of, Oxford University 
Press; provided by Oxford University Press and Copyright Clearance Center. 
Figure 6: Ex-vivo multiphoton microscopy if glioblastoma without the addition of exogenous 
contrast material. a shows the resection edge of the tumor composed of single invasive tumor 
cells (bright, larger cells) in a backgroud of normal brain. b shows the cellular portion of the the 
glioblastoma composed of large, pleomorphic cells with bright cytoplasms. Reproduced with 
permission from Leppert J, Krajewski J, Kantelhardt SR, Schlaffer S, Petkus N, Reusche E, et al: 
Multiphoton excitation of autofluorescence for microscopy of glioma tissue. Neurosurgery 
58:759-767; discussion 759-767, 2006. By permission of, Oxford University Press, provided by 
Oxford University Press and Copyright Clearance Center. 
Fig 7: Multimodal confocal reflectance and fluorscence microscopy. a: Images of meningioma. 
(a) reflactance mode image showing fibrous outer layers of meningeal whorls (dashed arrows), 
(b) fluorescence mode showing fluorescent meningeal cells arranged in nests (solid arrows), (c); 
corresponding hematoxylin and eosin-stained histologic section. Fig. 7(b); Images of low-grade 
astrocytoma. (a) reflectance mode showing blood vessel (dotted arrow) and disrupted neural 
network pattern. (b) fluorescence mode demonstrates glioma cells (solid arrows) with increased 
cellularity. (c) corresponding hematoxylin and eosin-stained histologic section.88 Reprodued with 
permission from Wirth D, Snuderl M, Sheth S, Kwon CS, Frosch MP, Curry W, et al: Identifying 
brain neoplasms using dye-enhanced multimodal confocal imaging. J Biomed Opt 17:026012, 
2012. 
Figure 8: Composite showing comparison of different tumors using standard Hematoxylin and 
Eosin, Two photon excited fluorescence (TPEF), coherent anti-Stokes raman scattering (CARS) 
and multimodal combination of TPEF and CARS. Images A-D, show metastasis of squamous 
cell carcinoma. TPEF and CARS highlight the boundaries of the architecture. Images E-H show 
a diffuse gilioma with moderate cellularity. TPEF demonstrates the cytological cellularity while 
CARS highlights the distorted architcural infrasturcure. Images I to L show the outer border of a 
lympha, with TPEF highluighting the vessels while CARS highlights the structureal detail. 
Images M to P show the central portion of the same lymphoma depicted in images I to L, 
showing increased density. Scale bars A and E: 500 micrometers, All others 5o micrometers. 
Reproduced with permission from Romeike BF, Meyer T, Reichart R, Kalff R, Petersen I, 
Dietzek B, et al: Coherent anti-Stokes raman scattering and two photon excited fluorescence for 
neurosurgery. Clin Neurol Neurosurg 131:42-46, 2015. With permission from Elsevier; 
provided by Elsevier and Copyright Clearance Center. 
Table 1: Summary of pertinent in-vivo microscopy studies for neurosurgical applications 
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Table 2:  Technical comparison between different imaging modalities 
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Table 2: Technical comparison between different imaging modalities 
 Depth of 
images 
Contrast 
agent used 
Sensitivity Specificity Current 
apparatus for 
Intraoperative 
use available 
L
S
C
E
Flexible 
probe 
100 µm Yes N/A N/A Yes*** 
Rigid 
probe 
80 µm10 Yes Relatively Low 
** 
Relatively Low** No 
Miniaturiz
ed 
250 µm15 Yes 91%*53 94%*53 Yes 
CRM 200-300 
µm
31
 
No N/A N/A No 
FLIM N/A No N/A N/A No 
Multiphoton 200 µm No N/A N/A No 
OCT Up to 
1000 µm 
No Relatively Low Relatively Low Yes 
Raman  25-80 µm No 93% 91% Yes 
Mass 
Spectrometry 
N/A No N/A N/A Yes 
Multimodal 
Fluorescence 
and 
reflectance 
N/A Yes 95%**** 100%**** No 
Multimodal 
CARS and 
two-photon 
microscopy 
N/A No N/A N/A No 
 
Abbreviations: CARS: Coherent antistokes raman spectroscopy; CRM: Confocal Refelectance 
Microscopy; FLIM: Fluorescence lifetime microscopy; LSCE: Laser scanning confocal 
endomicroscopy; N/A: No sufficient data available; OCT: Optical coherence tomography 
 
 * Sensitivity and specificity rates for gliomas diagnoses using rigid probe LSCE, rates for 
meningioma are 93% and 97% respectively53. 
** showed that rigid probe LSCE correctly identified 86% of gliomas, 78% of meningiomas but 
only 20% of metastatic tumors: Abstract publication; David Breuskin JD, Yoo-Jin Kim, Steffi Urbschat, 
Joachim Oertel: Confocal laser endomicroscopy – a novel technique of diagnostics in neurosurgery? 64th Annual 
Meeting of the German Society of Neurosurgery (DGNC) 26 - 29, 2013 
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***Flexible probes offer the smallest and most flexible form of miniaturization for possibly the 
most convenient and accessible imaging 
**** Sensitivity and specificity values for detecting normal vs. abnormal brain tissue. 
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Table 1: Summary of pertinent in-vivo microscopy studies for neurosurgical applications 
Method Authors, 
year 
Title Animal, 
ex-vivo, 
in-vivo 
Number of 
specimens/pa
tients 
Findings 
LS
CE
: 
Fl
ex
ib
le
 
Pr
o
be
 
Charalampa
ki P et al.,  
2015 
Endomicroscopy for real-
time histomorphologic 
diagnosis: our clinical 
experience with 150 brain 
and spinal tumor cases 
Ex-vivo 150 
specimens 
Histologic features 
were demonstrable 
using the technique in 
most brain primary and 
metastatic tumor types. 
Pavlov V et 
al., 2016 
Intraoperative probe-based 
confocal laser 
endomicroscopy in surgery 
and stereotactic biopsy of 
low-grade and high-grade 
gliomas: a feasibility study 
in humans 
In-vivo 9 patients Intravenous contrast 
agent Fluorescein 
enabled distinguishing 
normal from abnormal 
tissue. 
 
Intravenous contrast 
agent 5-aminolevulinic 
acid did not produce 
diagnosable images. 
LS
CE
: 
R
ig
id
 
Pr
o
be
 
Breuskin D 
et al.,  2013 
Confocal laser 
endomicroscopy in 
neurosurgery: a new 
technique with much 
potential 
Animal 
(normal 
pig 
brain), 
cultured 
cells  & 
ex-vivo  
50 specimens Histologic features 
were demonstrable 
using the technique in 
some brain primary 
tumors 
LS
CE
: 
M
in
ia
tu
riz
ed
 
Pr
o
be
 
Foersch S et 
al., 2012 
Confocal laser 
endomicroscopy for 
diagnosis and 
histomorphologic imaging 
of brain tumors in vivo 
Animal 
(Rat) & 
ex-vivo 
11- rats 
15 ex-vivo 
specimens 
Overall ability to 
provide a diagnosis in   
90.85% of cases 
Peyre M et 
al., 2013 
Miniaturized handheld 
confocal microscopy 
identifies focal brain 
invasion in a mouse model 
of aggressive meningioma 
Animal 
(mice) & 
ex-vivo 
20 mice Ability of method in 
identifying cytologic 
and architectural 
criteria of aggressive 
meningiomas including 
foci of infiltration  
Martirosyan 
NL et al., 
2016 
Prospective evaluation of 
the utility of intraoperative 
confocal laser 
endomicroscopy in patients 
with brain neoplasms using 
fluorescein sodium: 
experience with 74 cases 
In-vivo 
and ex-
vivo 
74 patients Specificity: 
94% gliomas  
93% meningiomas  
 
Sensitivity: 
 gliomas; 91%   
meningiomas; 97% 
C R M Georges J et Label-free microscopic Animal 5 rats Proof of Concept in the 
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al., 2014 assessment of glioblastoma 
biopsy specimens prior to 
biobanking 
(rats) ability of confocal 
reflectance microscopy 
to differentiate areas of 
viability and cellularity 
from necrosis prior to 
biobanking 
Mooney M 
et al., 2016 
Immediate ex-vivo 
diagnosis of pituitary 
adenomas using 
confocal reflectance 
microscopy: a proof-of-
principle study 
Ex-vivo 11 
Specimens 
(16 images) 
Confocal reflectance 
microscopy allows 
differentiation between 
pituitary adenoma and 
normal brain tissue 
O
pt
ic
al
 
Co
he
re
n
ce
 
To
m
o
gr
ap
hy
 
Bohringer 
HJ et al., 
2006 
Optical coherence 
tomography for 
experimental 
neuroendoscopy 
Ex-vivo 
(formalin 
fixed 
human 
brain) 
1 specimen Feasibility of OCT in 
neuroendoscopy to 
identifying vessels 
(greater than 50 
microns) 
Giese A et 
al., 2006 
Non-invasive 
intraoperative optical 
coherence tomography of 
the resection cavity during 
surgery of intrinsic brain 
tumors 
Ex-vivo N/A OCT analysis allowed 
the discrimination of 
normal brain tissue, 
invaded brain, solid 
tumor tissue, and 
necrosis 
Sarath S et 
al., 2015 
Detection of human brain 
cancer using visualization 
technique of optical 
coherence tomography 
Ex-vivo N/A Feasibility of non-
contact OCT with the 
aid of image processing 
in differentiating 
normal from tumoral 
tissue.  
Bohringer 
HJ et al., 
2009 
Imaging of human brain 
tumor tissue by near-
infrared laser coherence 
tomography 
Ex-vivo 
and in-
vivo 
9 patients OCT is sensitive for 
detecting tumor vs 
normal brain. OCT may 
not be specific due to 
artefacts such as 
hemorrhage 
Boppart SA 
et al., 1998 
Optical coherence 
tomography for 
neurosurgical imaging of 
human intracortical 
melanoma 
Ex-vivo 1 specimen OCT detects small 
subcortical deposits of 
tumor such as 
metastatic melanoma 
Assayag O, 
et al., 2013 
Imaging of non-tumorous 
and tumorous human brain 
tissues with full-field 
optical coherence 
tomography 
Ex-vivo 18 specimens Full field OCT images 
large areas of tissues 
and identifies tumorous 
vs. non tumorous 
tissue. OCT does not 
resolve individual cells 
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Finke M, et 
al., 2012 
Automatic scanning of 
large tissue areas in 
neurosurgery using optical 
coherence tomography 
Ex-vivo 6 specimens Ability of performing 
automatic OCT scans 
of large areas of tissue 
to identify foci of tumor 
M
u
lti
ph
o
to
n
 
M
ic
ro
sc
o
py
 
an
d 
FL
IM
 
Leppert J  et 
al., 2006 
Multiphoton excitation of 
autofluorescence for 
microscopy of glioma 
tissue 
Cultured 
cells, 
animal 
N/A Demonstrated high 
resolution images using 
endogenous 
fluorophores, and 
ability of imaging 
single malignant cells 
Kantelhardt 
S et al., 
2007 
Imaging of brain and brain 
tumor specimens by time-
resolved multiphoton 
excitation microscopy ex 
vivo 
Animal, 
ex-vivo 
N/A Ability of fluorescence 
lifetime in 
distinguishing normal 
brain tissue from tumor 
tissue which 
consistently have 
longer fluorescent 
lifetimes 
Kantelhardt 
S et al., 
2008 
Multiphoton excitation 
fluorescence microscopy of 
5-aminolevulinic acid 
induced fluorescence in 
experimental gliomas 
Cultured 
cells, 
animal 
N/A fluorescence lifetime 
profiles after the 
addition of fluorescent 
agent 5-ALA allow 
differentiation between 
tumor and normal brain 
more consistently than 
endogenous 
fluorophores 
M
as
s 
Sp
ec
tr
o
m
et
ry
 
Santagata S 
et al.,  2014 
Intraoperative mass 
spectrometry mapping of 
an onco-metabolite to 
guide brain tumor surgery 
Ex-vivo  N/A (at least 
35) 
Ability of mass 
spectrometry in 
identifying tumor 
including IDH-1 
mutations in real time 
from freshly biopsied 
tissues 
Agar NY et 
al., 2011 
Development of 
stereotactic mass 
spectrometry for brain 
tumor surgery 
Ex-vivo 22 specimens Ability of mass 
spectrometry in 
detecting tumor in 
tissue ex-vivo with 3 
dimensional mapping 
of biopsied sites  
Elkhaled A 
et al., 2014 
Characterization of 
metabolites in infiltrating 
gliomas using ex vivo 
Ex-vivo 126 
specimens 
Defining characteristic 
metabolic profiles in 
primary, recurrent and 
transformed gliomas 
and ability of profiles in 
predicting 
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Abbreviations: CARS: Coherent antistokes raman spectroscopy; CRM: Confocal Refelectance 
Microscopy; FLIM: Fluorescence lifetime microscopy; LSCE: Laser scanning confocal 
endomicroscopy; OCT: Optical coherence tomography 
 
transformation of low 
grade gliomas. 
Schafer KC 
et al., 2011 
Real time analysis of brain 
tissue by direct 
combination of ultrasonic 
surgical aspiration and 
sonic spray mass 
spectrometry 
Ex-vivo N/A Demonstrated ability of 
diagnosing tumors 
using direct and 
immediate mass 
spectrometry analysis 
of ultrasonically 
liquefied tissues. 
CR
M
 
&
 
Fl
u
o
re
sc
en
ce
 
Forest F et 
al.,  2015 
Ex vivo confocal 
microscopy imaging to 
identify tumor tissue on 
freshly removed brain 
sample 
Ex-vivo  19 specimens Ability of combined 
reflectance and 
fluorescence confocal 
microscopy in 
identifying brain 
tumors 
Wirth D  et 
al., 2012 
Identifying brain 
neoplasms using dye-
enhanced multimodal 
confocal imaging 
Ex-vivo 119 
specimens 
Ability of combined 
reflectance and 
fluorescence confocal 
microscopy in 
identifying brain 
tumors with good 
correlation with H&E 
histology. 
Snuderl M 
et al., 2013 
Dye-enhanced multimodal 
confocal imaging as a 
novel approach to 
intraoperative diagnosis of 
brain tumors 
Ex-vivo 37 specimens High sensitivity and 
specificity (95% and 
100% respectively) for 
detecting normal vs. 
abnormal brain tissue. 
CA
R
S 
&
 
Tw
o
 
Ph
o
to
n
 
Romeike BF  
et al.,  2015 
Coherent anti-Stokes 
Raman scattering and two 
photon excited 
fluorescence for 
neurosurgery 
Ex-vivo  55 specimens Demonstrated great 
ability to provide 
diagnoses without 
addition of contrast 
material  
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Highlights 
• Multiple imaging technologies for microscopy are outlined and evaluated 
• Advantages and disadvantages of pertinent microscopy methods are discussed 
• Current microscopic neurosurgical imaging requires refinement or in-vivo testing 
• Combination of different imaging methods provides best in-vivo imaging 
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Abbreviations 
 
In Vivo Microscopy in Neurosurgical Oncology 
 
Review Article 
 
 
2-HG:  2-hydroxyglutarate  
5ALA:  5-aminolevulinic acid  
BLZ-100:  tumor paint  
CARS:  coherent anti-stokes Raman scattering  
CRM:  confocal reflectance microscopy 
CRS:  coherent Raman spectroscopy 
LSCE: laser scanning confocal endomicroscopy  
FNa:  fluorescein sodium   
FLIM:  fluorescence lifetime microscopy  
ICG: indocyanine green  
OCT: optical coherence tomography 
SRS: stimulated Raman scattering  
 
 
 
 
 
 
 
 
